Molecular biology of gynecological cancer (Review)

被引:17
作者
Sonoda, Kenzo [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka, Fukuoka 8128582, Japan
基金
日本学术振兴会;
关键词
gynecological cancer; molecular biology; oncogenesis; angiogenesis; targeted therapy; SISO CELLS RCAS1; OVARIAN-CANCER; BRCA2; MUTATIONS; E-CADHERIN; ADENOMATOUS POLYPOSIS; PERSONALIZED MEDICINE; HUMAN-PAPILLOMAVIRUS; TUMOR HETEROGENEITY; FAMILY-HISTORY; SEROUS OVARIAN;
D O I
10.3892/ol.2015.3862
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is a pathological condition in which the balance between cell growth and death is disordered. Various molecules have been reported to be involved in the oncogenic process of invasion, metastasis and resistance to treatment. An exponential growth in the collection of genomic and proteomic data in the past 20 years has provided major advances in understanding the molecular mechanisms of human cancer, which has been applied to diagnostic and treatment strategies. Targeted therapies have been developed and adopted, particularly for advanced, refractory or recurrent cancers, depending on individual molecular profiles. The aim of the present review is to provide a report of the current literature regarding the molecular biology of gynecological cancers.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 134 条
  • [61] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15) : 1382 - 1392
  • [62] Inactivation of MYC reverses tumorigenesis
    Li, Y.
    Casey, S. C.
    Felsher, D. W.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2014, 276 (01) : 52 - 60
  • [63] Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells
    Liby, Tiera A.
    Spyropoulos, Perry
    Lindner, Haley Buff
    Eldridge, Juanita
    Beeson, Craig
    Hsu, Tien
    Muise-Helmericks, Robin C.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (03) : 532 - 543
  • [64] The retinoblastoma gene family in differentiation and development
    Lipinski, MM
    Jacks, T
    [J]. ONCOGENE, 1999, 18 (55) : 7873 - 7882
  • [65] PARP inhibitors in ovarian cancer: Current status and future promise
    Liu, Joyce F.
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 362 - 369
  • [66] Intrinsic tumour suppression
    Lowe, SW
    Cepero, E
    Evan, G
    [J]. NATURE, 2004, 432 (7015) : 307 - 315
  • [67] Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis
    Lu, Karen H.
    [J]. FAMILIAL CANCER, 2008, 7 (01) : 53 - 58
  • [68] MacDonald ND, 2000, CANCER RES, V60, P1750
  • [69] Retinoblastoma: From disease to discovery
    Madhavan, Jagadeesan
    Ganesh, Anuradha
    Kumaramanickavel, Govindasamy
    [J]. OPHTHALMIC RESEARCH, 2008, 40 (05) : 221 - 226
  • [70] Molecular pathologic diagnosis of epidermal growth factor receptor
    Maire, Cecile L.
    Ligon, Keith L.
    [J]. NEURO-ONCOLOGY, 2014, 16 : viii1 - viii6